Amgen to invest over $200M in India tech facility

Drugmaker Amgen to invest $200 million in India site, CEO says
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, CEO Robert Bradway said at the inauguration of the site on Monday.
Amgen plans $200M investment in India site, Reuters reports
Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’
Amgen Invests $200M in India Tech Hub to Boost AI-Driven Drug Development
Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI and data-driven drug development. CEO Robert Bradway, speaking at the sites inauguration,
Amgen opens new technology & innovation site in Hyderabad, to invest $200 million
The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further advance its pipeline of medicines, while creating significant opportunities for local talent.
Amgen's Bold $200M Move into India and Global Health Updates
Amgen invests $200M in India's tech center to leverage AI for drug development. The U.S. FDA seeks to rehire 300 staff including those for Neuralink. Saudi Arabia reaffirms $500M towards polio eradication.
Amgen to invest $200 million in India site, CEO says
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, Chief Executive Officer Robert Bradway said at the inauguration of the site on Monday.
Amgen to invest over $200M in India tech facility: report
Amgen (NASDAQ:AMGN) reportedly plans to invest over $200M in its newly opened technology and innovation center in Hyderabad, India. The site, which was officially opened on Monday, is expected to employ around 2,
Amgen opens new tech and innovation centre in Hyderabad with starting investment of $200m in 2025
HYDERABAD: US-based biopharma giant on Monday opened its new technology and innovation centre in Hyderabad with its CEO Robert Bradway announcing a $200 million investment commitment in the facility through 2025 with additional investments planned in future years.
Amgen plans $200 million investment in India site, CEO says
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, Chief Executive Officer Robert A. Bradway said at the inauguration of the site.
Amgen injects $200m in Hyd with new tech centre
Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...
ENDPOINTS NEWS12h
Am­gen plans fur­ther $200M in­vest­ment in new tech fa­cil­i­ty in In­dia
Amgen to invest $200M in new Hyderabad tech center through 2025, focusing on AI for drug development. Site opened Monday with ...
Top US biotech firm Amgen sets up innovation site in city
Amgen has set up this new centre in Hyderabad to further technologically develop its range of medicines. It is developing the ...
devdiscourse6h
Health Industry Updates: Key Developments and Investments
Recent developments in the health sector include Pfizer appointing Patrizia Cavazzoni as Chief Medical Officer and Amgen ...